CUSIP: 62818Q104
Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,824,645
-
Share change
-
-59,222
-
Total reported value
-
$35,288,461
-
Put/Call ratio
-
23%
-
Price per share
-
$3.26
-
Number of holders
-
55
-
Value change
-
-$283,914
-
Number of buys
-
23
-
Number of sells
-
21
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2019
-
Previous quarter:
Q2 2019
Recent filing periods for CUSIP 62818Q104:
Institutional Holders of MUSTANG BIO INC - COM (MBIO) as of Q3 2019
As of 30 Sep 2019,
MUSTANG BIO INC - COM (MBIO) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,824,645 shares.
The largest 10 holders included
Consonance Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, 683 Capital Management, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, HIGHLAND CAPITAL MANAGEMENT FUND ADVISORS, L.P., NORTHERN TRUST CORP, and Nuveen Asset Management, LLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.